Evidence map›Paper›PMID 30340493›Full record

ArticleReproductive biology and endocrinology : RB&E2018

Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry.

Gabriela García-Jiménez, Teresa Zariñán, Rocío Rodríguez-Valentín, Nancy R Mejía-Domínguez, Rubén Gutiérrez-Sagal, Georgina Hernández-Montes, Armando Tovar, Fabián Arechavaleta-Velasco, Patricia Canto, Julio Granados and 4 more

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Effects ofFrontiers in endocrinology · 2021
    Article
  9. Pharmacogenetics of FSH Action in the Female.Frontiers in endocrinology · 2019
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Gabriela García-JiménezInstituto Valenciano de Infertilidad (IVINSEMER), Thiers 96, Col. Nueva Anzurez, CP 11590, Mexico City, Mexico.
Teresa ZariñánRed de Apoyo a la Investigación (RAI), Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México (UNAM)-Instituto Nacional de Ciencias Médicas y Nutrición SZ (INCMNSZ), Calle Vasco de Quiroga 15, Tlalpan, 14000, Ciudad de Mexico, Mexico.
Rocío Rodríguez-ValentínCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Av. Universidad 655, CP 62100, Cuernavaca, Mor, Mexico.
Nancy R Mejía-DomínguezRed de Apoyo a la Investigación (RAI), Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México (UNAM)-Instituto Nacional de Ciencias Médicas y Nutrición SZ (INCMNSZ), Calle Vasco de Quiroga 15, Tlalpan, 14000, Ciudad de Mexico, Mexico.
Rubén Gutiérrez-SagalRed de Apoyo a la Investigación (RAI), Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México (UNAM)-Instituto Nacional de Ciencias Médicas y Nutrición SZ (INCMNSZ), Calle Vasco de Quiroga 15, Tlalpan, 14000, Ciudad de Mexico, Mexico.
Georgina Hernández-MontesRed de Apoyo a la Investigación (RAI), Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México (UNAM)-Instituto Nacional de Ciencias Médicas y Nutrición SZ (INCMNSZ), Calle Vasco de Quiroga 15, Tlalpan, 14000, Ciudad de Mexico, Mexico.
Armando TovarDepartment of Physiology of Nutrition, INCMNSZ, Mexico City, Mexico.
Fabián Arechavaleta-VelascoResearch Unit in Reproductive Medicine, UMAE Hospital de Ginecoobstetricia "Luis Castelazo Ayala", Río de la Magdalena 289, Tizapán San Ángel, Mexico City, 01090, Mexico.
Patricia CantoFacultad de Medicina, UNAM, Ciudad Universitaria, Mexico City, Mexico.
Julio GranadosDepartment of Transplantation, INCMNSZ, Mexico City, Mexico.
Hortensia Moreno-MaciasUniversidad Autónoma Metropolitana-Iztapalapa, Av. San Rafael Atlixco 186, Leyes de Reforma 1ra. Secc., Mexico City, 09340, Mexico.
Teresa Tusié-LunaUnidad de Biología Molecular y Medicina Genómica, UNAM-INCMNSZ, Mexico City, Mexico.
Antonio PellicerInstituto Valenciano de Infertilidad (IVINSEMER), Thiers 96, Col. Nueva Anzurez, CP 11590, Mexico City, Mexico.
Alfredo Ulloa-AguirreRed de Apoyo a la Investigación (RAI), Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México (UNAM)-Instituto Nacional de Ciencias Médicas y Nutrición SZ (INCMNSZ), Calle Vasco de Quiroga 15, Tlalpan, 14000, Ciudad de Mexico, Mexico. aulloaa@unam.mx.ORCID http://orcid.org/0000-0002-9532-3886
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstituto Nacional de Salud Pública · MXUniversidad Autónoma Metropolitana · MX

Funding

Consejo Nacional de Ciencia y Tecnología 86881 and 240619Coordinación de la Investigación Científica, UNAM RAI
6 · The paper itself

Abstract

backgroundFSHR SNPs may influence the ovarian sensitivity to endogenous and exogenous FSH stimulation. Given the paucity of data on the FSHR c.919A > G, c.2039A > G and - 29G > A SNPs in Hispanic population, we here analyzed their frequency distribution in Mexican mestizo women.

methodsSamples from 224 Mexican mestizo women enrolled in an IVF program as well as a genotype database from 8182 Mexican mestizo subjects, were analyzed for FSHR SNPs at positions c.919, c.2039 and - 29G > A. Association between the genetic variants and reproductive outcomes was assessed.

resultsThe c.919 and c.2039 SNPs were in strong linkage disequilibrium and their corresponding genotype frequencies in the IVF group were: AA 46.8%, AG 44.2%, and GG 8.9%, and AA 41.9%, AG 48.2% and GG 9.8%, respectively. For the -29G > A SNP, genotype frequencies were 27% (GG), 50% (GA) and 23% (AA). In normal oocyte donors with the c.2039 GG genotype, the number of oocytes recovered after ovarian stimulation (COS) were significantly (p < 0.01) lower than in those bearing other genotypes in this or the -29G > A SNP. Analysis of the large scale database revealed that both allelic and genotype frequencies for the three SNPs were very similar to those detected in the IVF cohort (p ≥ 0.38) and that female carriers of the c.2039 G allele tended to present lower number of pregnancies than women bearing the AA genotype; this trend was stronger when women with more Native American ancestry was separately analyzed (OR = 2.0, C.I. 95% 1.03-3.90, p = 0.04). There were no differences or trends in the number of pregnancies among the different genotypes of the -29G > A SNP.

conclusionsThe frequency of the GG/GG combination genotype for the c.919 and c.2039 SNPs in Mexican hispanics is among the lowest reported. The GG genotype is associated with decreased number of oocytes recovered in response to COS as well as to lower pregnancy rates in Hispanic women from the general population. The absence of any effect of the -29AA genotype on the response to COS, indicates that there is no need to perform this particular genotype testing in Hispanic women with the purpose of providing an individually-tailored COS protocol.

Indexed as

Fertilization in VitroPolymorphism, Single NucleotideAdultAllelesCohort StudiesFemaleGene FrequencyGenotypeHispanic or LatinoHumansLinkage DisequilibriumMexicoOvulation InductionPregnancyPregnancy RateReceptors, FSHReceptors, FSHAssisted reproductive techniquesFemale infertilityFollicle stimulating hormoneFSHR gene SNPsInfertilityOocyte donationOvulation induction

Identifiers

PMID30340493
PMCPMC6195735
OpenAlexW2896999669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.